medRxiv·4 OctPlasma immune signatures associate with neurodegeneration in frontotemporal lobar degenerationPreprint: cohort study of 177 peopleBiomarkersPaper
medRxiv·20 SepMyo-inositol as a spectroscopic marker of neuroinflammation in frontotemporal lobar degenerationPreprint: study in peopleBiomarkersPaper
PsyArXiv·12 SepA call for a mechanistic-neutral nomenclature replacing “neuromelanin-sensitive” imagingPreprint: reviewBiomarkersPaper
bioRxiv·31 AugCerebrospinal fluid YWHAG:NPTX2 ratio predicts clinical severity and future phenoconversion in frontotemporal lobar degenerationPreprint: cohort study in peopleBiomarkersPaper
Brain Communications·5 AugEducational attainment and sex modulate clinical outcomes in genetic frontotemporal dementiaStudy in peoplePopulationsPaper
Research Square·4 AugThe Ignite app detects early cognitive impairment and tracks disease severity in genetic frontotemporal dementiaPreprint: study in peopleBiomarkersPaper
AAIC 2025 Abstract·10 JanFrequent at‐home multimodal measurements are more sensitive to progression than the gold‐standard clinic‐based ADAS‐Cog composite scaleStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·8 JanSex, education and race/ethnicity have distinct effects on amyloid and tau‐PET statusStudy in peoplePopulationsPaper
AAIC 2025 Abstract·26 DecTMEM106B modulates disease severity in genetic frontotemporal dementia phenoconvertersStudy in peoplePopulationsPaper
AAIC 2025 Abstract·26 DecAlzheimer's disease and its severity reduce MEG responses to unexpected auditory stimuliStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecMultidimensional cognitive deficits in the typical and atypical variants of Alzheimer's diseaseStudy in peoplePopulationsPaper
AAIC 2025 Abstract·25 DecStructure‐function decoupling in genetic frontotemporal dementiaStudy in peopleMechanismsPaper
AAIC 2025 Abstract·23 DecFrequent at‐home multimodal measurements are more sensitive to progression than the gold‐standard clinic‐based ADAS‐Cog composite scaleStudy in peopleBiomarkersPaper